ESSA Pharma Inc. is pleased to announce that, further to the announcement made on July 8, 2019, the High Court of Justice in England and Wales has today sanctioned the scheme of arrangement under Part 26 of the U.K. Companies Act 2006, pursuant to which ESSA will acquire all of the issued and outstanding shares of Realm Therapeutics plc.
July 30, 2019
· 5 min read